Supplements
What Does Anti-Müllerian Hormone Tell You About Your Hormones?
Anti-Müllerian hormone is one of the most clinically informative markers in reproductive endocrinology — yet most people only hear about it when they're already worried about fertility. Understanding what AMH actually measures, why it fluctuates, and what genuinely influences it can help you take meaningful action long before a crisis point.
What Does Anti-Müllerian Hormone Tell You About Your Hormones?
AMH is a reliable marker of your ovarian reserve — the pool of remaining follicles in your ovaries — and elevated AMH often signals PCOS, while very low AMH suggests diminished reserve. The main caveat: AMH is not a fertility sentence. It predicts egg quantity, not quality, and lifestyle factors including vitamin D status and inflammation meaningfully influence where your number lands.
---
What Is Anti-Müllerian Hormone and Why Does It Matter?
Anti-Müllerian hormone (AMH) is a glycoprotein produced by the granulosa cells of small antral and preantral follicles in the ovaries. Unlike most reproductive hormones — estradiol, LH, FSH — AMH remains relatively stable across the menstrual cycle, which makes it an unusually clean signal in an otherwise noisy hormonal environment (La Marca et al., Human Reproduction Update 2010; PMID: 19589796).
At its core, AMH tells you two things:
- How many small follicles remain. A higher AMH generally means a larger pool of developing follicles.
- Whether follicle recruitment is dysregulated. In polycystic ovary syndrome (PCOS), AMH is often 2–4 times higher than average because excess small follicles accumulate and fail to mature normally.
Think of AMH as a census of your ovarian reserve, not a passport for fertility. A woman with a low AMH can conceive naturally; a woman with a high AMH may struggle for unrelated reasons. Context is everything.
Reference Ranges by Age
| Age | Low (pmol/L) | Normal Range (pmol/L) | High (pmol/L) |
|---|---|---|---|
| 25–29 | < 7.0 | 7.0–38.0 | > 38.0 |
| 30–34 | < 5.5 | 5.5–30.0 | > 30.0 |
| 35–39 | < 3.5 | 3.5–22.0 | > 22.0 |
| 40–44 | < 1.5 | 1.5–10.0 | > 10.0 |
pmol/L values; multiply by ~0.14 to convert to ng/mL. Ranges vary slightly by laboratory and assay.
Lab values alone rarely tell the full story. If your results feel puzzling despite a normal panel, what does TSH tell you about your hormones offers a useful parallel for understanding how single markers interact with broader endocrine function.
---
AMH and PCOS: When Your Number Is Elevated
Polycystic ovary syndrome is the most common endocrine disorder in people with ovaries, affecting an estimated 6–15% of reproductive-age women depending on diagnostic criteria (Bozdag et al., Human Reproduction 2016; PMID: 27664216). AMH elevation is so consistent in PCOS that some researchers have proposed it as a standalone diagnostic marker.
In PCOS, granulosa cells overproduce AMH, which then inhibits the normal FSH-driven maturation cascade. The result: follicles arrest at the small antral stage, accumulate in the ovary, and produce androgens like testosterone rather than progressing to ovulation. Clinically, this manifests as:
- Irregular or absent periods
- Elevated androgens (acne, hirsutism)
- Difficulty conceiving
- Metabolic dysregulation including insulin resistance
The link between AMH and insulin resistance is particularly important. Hyperinsulinemia amplifies androgen production, which worsens follicle arrest, which keeps AMH elevated — a self-reinforcing loop. Research in the Journal of Clinical Endocrinology & Metabolism found that improving insulin sensitivity through lifestyle intervention reduced AMH levels in women with PCOS (Palomba et al., JCEM 2010; PMID: 20702520).
If you are tracking fasting glucose or HbA1c alongside AMH, what does fasting glucose tell you about your hormones and what does HbA1c tell you about your hormones give important context for the metabolic side of this picture.
---
AMH and Diminished Ovarian Reserve: When Your Number Is Low
At the other end of the spectrum, a low AMH for age signals diminished ovarian reserve (DOR) — fewer remaining follicles than expected. This becomes clinically significant for anyone considering assisted reproduction, since IVF response is strongly predicted by AMH (Broer et al., Fertility and Sterility 2011; PMID: 21247558).
Common causes of lower-than-expected AMH include:
- Age-related follicle depletion (the primary driver after 35)
- Autoimmune oophoritis — immune-mediated follicle destruction
- Prior ovarian surgery — even cyst removal can reduce reserve
- Endometriosis — deeply infiltrating disease and ovarian endometriomas accelerate follicle loss
- Chemotherapy or pelvic radiation
- Vitamin D deficiency — more on this below
- Chronic low-grade inflammation
It is worth stating plainly: a low AMH is not a diagnosis of infertility. AMH predicts quantity of eggs available for stimulation; egg quality — which is the dominant variable in embryo viability — is not captured by AMH and is primarily determined by age and mitochondrial health.
---
What Genuinely Influences AMH Levels?
This is where the conversation becomes actionable. Several modifiable factors have been shown in controlled research to affect AMH.
Vitamin D3
Vitamin D receptors are expressed in granulosa cells, and VDR activation appears to regulate AMH gene expression. A meta-analysis of observational studies found a consistent positive association between 25(OH)D levels and AMH across reproductive-age populations, with vitamin D-deficient women showing significantly lower AMH than replete peers (Dąbrowska-Galas et al., Nutrients 2019; PMID: 31450655).
Interventional data are more limited, but existing studies suggest that correcting deficiency (serum 25(OH)D below 50 nmol/L) to sufficiency (75–100 nmol/L) may partially restore AMH rather than simply correlating with it. This is biologically plausible: granulosa cells without adequate VDR signaling have impaired steroidogenesis and reduced follicle survival.
Inflammation and Oxidative Stress
Chronic low-grade inflammation, often indexed by high-sensitivity CRP, accelerates follicle apoptosis. Follicles are metabolically demanding structures, and sustained oxidative stress depletes the antioxidant defenses within granulosa cells, triggering follicle loss before it would otherwise occur. Understanding your inflammatory baseline — what does CRP tell you about your hormones — is relevant here.
Omega-3 Fatty Acids
EPA and DHA modulate prostaglandin pathways and reduce inflammatory cytokines that damage follicular microenvironment. Early-stage clinical work suggests omega-3 supplementation improves egg quality markers in IVF cycles, though large-scale AMH-specific RCTs are still needed.
Body Composition
Both obesity and very low body fat affect AMH in opposite directions. Adipose tissue is hormonally active; excess visceral fat drives insulin resistance and inflammation that suppress ovarian function. Conversely, extreme leanness (common in athletes and those with restrictive eating patterns) can reduce AMH through hypothalamic suppression of the entire HPG axis.
Oral Contraceptive Use
This one surprises many people: combined hormonal contraceptives suppress AMH by 20–30% on average due to reduced follicle recruitment during pill use. This suppression is reversible; AMH typically returns to pre-pill levels within 1–3 months of discontinuation (Daan et al., Human Reproduction 2011; PMID: 21183514).
---
Confirmed Findings: What AMH Can and Cannot Tell You
AMH is genuinely informative, but the wellness internet has overstated what a single number can predict. Here is an honest breakdown:
| AMH Can Tell You | AMH Cannot Tell You |
|---|---|
| Approximate remaining follicle pool | Whether you will conceive naturally |
| Likely IVF response (low, normal, high) | Egg quality or chromosomal integrity |
| Whether PCOS pattern is present | Exact timeline to menopause |
| Whether ovarian reserve is declining faster than expected | Whether embryos will implant |
| Whether vitamin D or metabolic intervention may help | Which partner is contributing to difficulty conceiving |
AMH also does not fluctuate meaningfully within a cycle, which means you do not need to time the test to a specific cycle day — a practical advantage over FSH testing.
---
AMH and Endometriosis: A Special Case Worth Understanding
Endometriosis affects an estimated 10% of reproductive-age people and is chronically underdiagnosed — often by a decade or more. Ovarian endometriomas (chocolate cysts) are particularly damaging to ovarian reserve because they replace healthy ovarian cortex and trigger ongoing oxidative stress within the follicle pool.
Women with endometriosis consistently show lower AMH than age-matched controls, and the reduction correlates with disease severity and the presence of bilateral endometriomas (Uncu et al., Fertility and Sterility 2013; PMID: 23375132). Surgical removal of endometriomas, while necessary in some cases, carries its own risk of further reducing AMH by inadvertently removing healthy follicle-bearing tissue.
This is one area where early testing and early intervention genuinely matter. If AMH is trending low in someone in their late 20s or early 30s with symptoms suggestive of endometriosis — painful periods, pain with intercourse, pelvic pain outside of menstruation — it is worth discussing both the diagnostic workup and ovarian reserve preservation with a reproductive endocrinologist.
---
What This Means for Your Formula
Ones uses blood work and health history to build personalized supplement formulas — and AMH results, alongside FSH, LH, and estradiol, form part of the hormonal picture an AI health practitioner evaluates.
For individuals with low AMH or evidence of diminished ovarian reserve, Ones may include:
- Vitamin D3 + K2 (MK-7): Ones pairs D3 with MK-7 to support calcium routing alongside VDR-mediated granulosa cell function. Given the consistent AMH-vitamin D correlation in research, correcting deficiency is one of the most evidence-grounded interventions available — learn why D3 and K2 work together.
- Omega-3 (EPA/DHA): Dosed to clinical ranges to reduce follicular oxidative stress and prostaglandin-mediated inflammation in the ovarian microenvironment.
- Endocrine Support (System Blend): Ones' proprietary Endocrine Support blend is formulated for individuals with hormonal pattern irregularities, including those where AMH and cycle regularity are affected.
For individuals with elevated AMH consistent with PCOS, the formula shifts: the focus moves toward insulin sensitization support (inositol-adjacent mechanisms, chromium, alpha-lipoic acid) and androgen modulation rather than reserve preservation.
Ones does not offer a one-size-fits-all hormone formula. The specific combination and dose depend on what your full panel reveals — which is exactly the point.
---
Key Takeaways
- AMH measures follicle quantity, not egg quality. A low number does not mean you cannot conceive; a high number does not guarantee easy fertility.
- Elevated AMH most commonly signals PCOS, where follicle arrest and androgen excess create a self-reinforcing hormonal loop that also affects metabolic health.
- Vitamin D deficiency is one of the most modifiable influences on AMH. Correcting deficiency to sufficiency (75–100 nmol/L serum 25(OH)D) has biological plausibility for supporting granulosa cell function.
- Oral contraceptives temporarily suppress AMH by 20–30%; levels normalize within 1–3 months of stopping, so test timing matters if you've recently discontinued hormonal contraception.
- Endometriosis accelerates ovarian reserve decline and is frequently confirmed years after AMH begins trending low — early testing is worthwhile if symptoms are present.
- Personalized supplementation — adjusted for whether AMH is high or low, and why — is more effective than a generic hormone blend. Ones evaluates the full hormonal context before building a formula.
---
This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before making changes to your supplement regimen or for interpretation of hormonal lab results.